OKYO Pharma Ltd has recorded no insider trading activity within the past ninety days. The most recent transaction occurred on September 15, 2023, involving a purchase by John P. Brancaccio. Previous historical filings indicate multiple acquisitions by executives, including Gabriele M. Cerrone and Gary S. Jacob, dating back to 2022.